Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

International perspectives on antiretroviral resistance. Nucleoside reverse transcriptase inhibitor resistance.

Journal of acquired immune deficiency syndromes (1999) - 1 Mar 2001

Loveday C

Abstract excerpt

Nucleoside reverse transcriptase inhibitors (NRTIs) comprise the first class of drug with proven antiretroviral efficacy against HIV-1, and the first in which drug resistance was reported. Ongoing research in the area of NRTI resistance and cross-resistance contributes much to what we know about the failure of antiretroviral therapy. The genetic mutation patterns responsible for resistance to the available NRTIs...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Dideoxynucleosides
Share to Drug Resistance, Microbial
Share to Drug Resistance, Multiple

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to HIV Protease

Share to HIV Reverse Transcriptase

Share to Lamivudine

Share to Reverse Transcriptase Inhibitors

Share to Zidovudine

Source

Identifiers

PMID: 11264998
DOI: 10.1097/00042560-200103011-00003

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

International perspectives on antiretroviral resistance. Nucleoside reverse transcriptase inhibitor resistance.PMID 11264998Read ↗

International perspectives on antiretroviral resistance. Resistance to protease inhibitors.Semantic proximity Read ↗

HIV drug resistance in the era of contemporary antiretroviral therapy: A clinical perspective.Semantic proximity Read ↗

Confronting the Emergence of Drug-Resistant HIV Type 1: Impact of Antiretroviral Therapy on Individual and Population ResistanceSemantic proximity Read ↗

HIV-1 antiretroviral resistance: scientific principles and clinical applications.Semantic proximity Read ↗

The Phenomenon of Antiretroviral Drug Resistance in the Context of Human Immunodeficiency Virus Treatment: Dynamic and Ever Evolving Subject MatterSemantic proximity Read ↗

Antiviral Resistance in the Genomic Era: Molecular Mechanisms, Clinical Challenges, and Pharmacogenetic Perspectives.Semantic proximity Read ↗

Resistance to antiretroviral drugs.Semantic proximity Read ↗

Protease inhibitor resistance update: where are we now?Semantic proximity Read ↗

Mechanisms of anti-retroviral drug resistance: implications for novel drug discovery and development.Semantic proximity Read ↗

Antiviral Drug Resistance and the Need for Development of New HIV-1 Reverse Transcriptase InhibitorsSemantic proximity Read ↗

International perspectives on antiretroviral resistance. Clinical utility of resistance testing: retrospective and prospective data supporting use and current recommendations.Semantic proximity Read ↗

International perspectives on antiretroviral resistance. Phenotypic and genotypic resistance assays: methodology, reliability, and interpretations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.